Goodwin advised Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) on its definitive agreement with Catalent, Inc., for Catalent to acquire all of the outstanding shares of Juniper at…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now